Retatrutide-specific body-weight data has not been published, but semaglutide and tirzepatide studies measured 20% to 40% higher exposure in people weighing 120 to 155 lb than in a 185 lb reference
Taking steps now to complete your screening can make a significant difference in your long-term health
And it's very likely, I think, that micro-dosing will find its way in some of these areas like addiction or perhaps Alzheimer's disease, where you're really amplifying the anti-inflammatory aspects of the drug and not so much the appetite-reducing effects
(3) M Chennaoui, D Lger, and D Gomez-Merino (2020) Sleep and the GH/IGF-1 axis: Consequences and countermeasures of sleep loss/disorders Sleep Medicine Reviews, Volume 49, February 2020, Page 101223
Existing findings suggest that butyrates influence on PTMs likely extends beyond the four types mentioned above